Attention Shareholders: Don’t Miss the Eiger Biopharmaceuticals Class Action Deadline – Johnson Fistel Urges You to Submit Your EIGR Losses!
Eiger BioPharmaceuticals Class Action Lawsuit Update Shareholder rights law firm Johnson Fistel, LLP has announced that a class action lawsuit has commenced on behalf of investors of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR). The class action is on behalf of shareholders who purchased Eiger securities between March 10, 2021 and October… SAN DIEGO, Dec. 05, 2022…